BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

  1. Homepage
  2. Medicinal products
  3. Pharmacovigilance
  4. Risk information

Information Letter on Palexia® 20 mg/ml oral solution (tapentadol): administration to children and adolescents in hospitals

2018.12.06

Active substance: tapentadol

The company Grünenthal is circulating information on a new dosing pipette for weight-based dosing in children with a body weight of more than 16 kg.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 1MB, File does not meet accessibility standards